A major breakthrough in cancer study is emerging with the use of VHH fragments to reactivate mutated p53. This vital cancer inhibitor protein is frequently disabled in several types of tumors, leading uncontrolled https://socialbuzztoday.com/story7465804/nanobodies-restore-p53-a-potential-approach-for-malignant-therapy